Patented 3D Bioprinters and Related Products - Genetic Technology TOE

USD 250.00

* Required Fields

USD 250.00


Be the first to review this product

This edition of the Genetic Technology TOE depicts a range of innovations that have been patented in the space of 3D bioprinters. The issue also focuses on some of the key patents that have been filed around the space of 3D bioprinting, related products and bioinks that are needed for the development of 3D tissue models. Insights have been provided around the potential impact of these biomanufacturing processes, across the pharmaceutical and life science space. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisi

Table of Contents

Patented 3D Bioprinters and Related Products - Genetic Technology TOEOverview – 3D Bioprinters and Related ProductsUniversity Spin Off Technology Developed into 3D BioprinterRegenHU Carries a Range of 3D Bioprinters and Supported BiomaterialsKey Granted Patents from the Top Applicants (2015) Key Granted Patents from the Top Applicants (2014-2016) Hybrid 3D Bioprinter that can Print a Combination of Soft and Hard TissuesStrategic PerspectivesAnalyst InsightsIndustry Interactions

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.